Related Experiment Video
Updated: Jan 27, 2026
07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.6K
Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
Yoojin Seo1, Hyung-Sik Kim1,2, In-Sun Hong3,4
1Institute of Translational Dental Sciences, School of Dentistry, Pusan National University, Yangsan 50612, Republic of Korea.
Stem Cells International
|April 3, 2019
Summary
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show therapeutic potential for immune disorders. These EVs mimic parent MSCs, regulating immune cells and offering a promising alternative to cell therapy.
Area of Science:
- Immunology
- Cell Biology
- Regenerative Medicine
Background:
- Mesenchymal stem cells (MSCs) exhibit immunomodulatory properties beneficial for inflammatory and autoimmune diseases.
- Paracrine factors mediate MSCs' immune regulatory functions, with extracellular vesicles (EVs) playing a key role.
- EVs, including exosomes and microvesicles, carry bioactive molecules that influence target cell characteristics.
Purpose of the Study:
- To review the therapeutic potential of MSC-derived EVs (MSC-EVs) in treating immune-related disorders.
- To discuss the mechanisms by which MSC-EVs modulate immune cells and the immune microenvironment.
- To highlight MSC-EVs as a promising cell-free therapeutic strategy.
Main Methods:
- Literature review of studies evaluating MSC-EV function in inflammatory disease models.
- Analysis of research on MSC-EV interactions with various immune effector cells.
- Examination of the molecular cargo (cytokines, transcription factors, microRNAs) within MSC-EVs.
Main Results:
- MSC-EVs replicate the therapeutic effects of parent MSCs.
- MSC-EVs regulate immune cell proliferation, maturation, polarization, and migration.
- MSC-EVs modulate the immune microenvironment by delivering bioactive molecules.
Conclusions:
- MSC-EVs represent a novel therapeutic tool for immune-related disorders.
- MSC-EVs offer advantages over conventional cell therapy, addressing efficacy and toxicity concerns.
- Further research into MSC-EVs holds promise for advancing treatments for immune diseases.
More Related Videos
Related Concept Videos
01:33Adult Stem Cells
33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
00:58Embryonic Stem Cells
32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
00:57Embryonic Stem Cells
4.8K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.8K
01:13Induced Pluripotent Stem Cells
27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
01:42The Extracellular Matrix
88.5K
Overview
88.5K
01:13Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K